Utility of line probe assay for the early detection of multidrug-resistant pulmonary tuberculosis
Open Access
- 1 January 2015
- journal article
- research article
- Published by Medknow in Journal of Global Infectious Diseases
- Vol. 7 (2) , 60-5
Abstract
Background: Despite endorsement of the line probe assay (LPA) for the diagnosis of drug-resistant pulmonary tuberculosis patients, there is limited data available on the performance of LPAs in India, especially from high burden states like Maharashtra, for the early diagnosis and detection of drug resistance, in order to initiate timely and appropriate treatment. Objective: To evaluate the utility of the line probe assay (LPA) for the early diagnosis of drug-resistant pulmonary tuberculosis as compared to the 'Gold standard' 1% proportion method (PM). Materials and Methods: A total of 687 patients suspected of pulmonary tuberculosis were screened. One hundred samples (95 sputum and 5 BAL), positive for Acid Fast Bacilli (AFB) by Ziehl Neelson (ZN) smears, were included in the study. Digested and decontaminated specimens were subjected directly to the LPA (Genotype [email protected] plus assay) and were processed in parallel using the conventional culture on the Lowenstein-Jensen (LJ) medium followed by drug susceptibility testing (DST) using the PM. Results: All the 100 samples gave interpretable results on LPA with a turnaround time of 24-48 hours as opposed to six to eight weeks taken by the 1% proportion method. Sensitivity for the detection of rifampicin, isoniazid, and multidrug resistance (MDR) was 98.1, 92.1, and 95%, respectively, with a specificity of 97.8% for rifampicin and 98.33% for MDR detection. It also had the additional advantage of allowing a study of mutation patterns. Conclusions: High performance characteristics and a short turnaround time makes LPA an excellent diagnostic tool, for an early and accurate diagnosis, in a high MDR- TB-prevalent region, as reflected from our data.Keywords
This publication has 17 references indexed in Scilit:
- Utility of GenoType MTBDRplus assay in rapid diagnosis of multidrug resistant tuberculosis at a tertiary care centre in IndiaIndian Journal of Medical Microbiology, 2012
- Rapid Diagnosis of Extensively Drug-Resistant Tuberculosis by Use of a Reverse Line Blot Hybridization AssayJournal of Clinical Microbiology, 2011
- Laboratory Diagnosis of Tuberculosis in Resource-Poor Countries: Challenges and OpportunitiesClinical Microbiology Reviews, 2011
- Application of Genotype MTBDRplus in rapid detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin in a high volum laboratory in Southern ChinaMolecular Biology Reports, 2010
- Comparison of two commercial assays for the characterization of rpoB mutations in Mycobacterium tuberculosis and description of new mutations conferring weak resistance to rifampicinJournal of Antimicrobial Chemotherapy, 2009
- Mechanisms of heteroresistance to isoniazid and rifampin ofMycobacterium tuberculosisin Tashkent, UzbekistanEuropean Respiratory Journal, 2008
- Multidrug-resistant tuberculosis: rapid detection of resistance to rifampin and high or low levels of isoniazid in clinical specimens and isolatesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Evaluation of the Genotype MTBDR Assay for Rapid Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis IsolatesJournal of Clinical Microbiology, 2006
- Comparison of Two Commercially Available DNA Line Probe Assays for Detection of Multidrug-Resistant Mycobacterium tuberculosisJournal of Clinical Microbiology, 2006
- Hetero-resistance: an under-recognised confounder in diagnosis and therapy?Journal of Medical Microbiology, 2001